186 related articles for article (PubMed ID: 28291340)
1. Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P
Dyckman AJ
J Med Chem; 2017 Jul; 60(13):5267-5289. PubMed ID: 28291340
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine 1-phosphate receptor 1 agonists: a patent review (2013-2015).
Guerrero M; Urbano M; Roberts E
Expert Opin Ther Pat; 2016; 26(4):455-70. PubMed ID: 26947494
[TBL] [Abstract][Full Text] [Related]
3. ST-2191, an Anellated Bismorpholino Derivative of Oxy-Fingolimod, Shows Selective S1P
Stepanovska Tanturovska B; Zivkovic A; Imeri F; Homann T; Kleuser B; Stark H; Huwiler A
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500564
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of new ligands for targeting the S1P1 receptor.
Schilson SS; Keul P; Shaikh RS; Schäfers M; Levkau B; Haufe G
Bioorg Med Chem; 2015 Mar; 23(5):1011-26. PubMed ID: 25656338
[TBL] [Abstract][Full Text] [Related]
5. Exploration of Tetrahydroisoquinoline- and Benzo[
Cha E; Kim J; Gotina L; Kim J; Kim HJ; Seo SH; Park JE; Joo J; Kang M; Lee J; Hwang H; Kim HJ; Pae AN; Park KD; Park JH; Lim SM
J Med Chem; 2023 Aug; 66(15):10381-10412. PubMed ID: 37489798
[TBL] [Abstract][Full Text] [Related]
6. Morpholino Analogues of Fingolimod as Novel and Selective S1P
Stepanovska B; Zivkovic A; Enzmann G; Tietz S; Homann T; Kleuser B; Engelhardt B; Stark H; Huwiler A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899717
[TBL] [Abstract][Full Text] [Related]
7. An update on sphingosine-1-phosphate receptor 1 modulators.
Marciniak A; Camp SM; Garcia JGN; Polt R
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3585-3591. PubMed ID: 30409535
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Potential of the Modulation of Sphingosine-1-Phosphate Receptors.
Delgado A; Martínez-Cartro M
Curr Med Chem; 2016; 23(3):242-64. PubMed ID: 26639095
[TBL] [Abstract][Full Text] [Related]
9. Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P
Xiao HY; Watterson SH; Langevine CM; Srivastava AS; Ko SS; Zhang Y; Cherney RJ; Guo WW; Gilmore JL; Sheppeck JE; Wu DR; Li P; Ramasamy D; Arunachalam P; Mathur A; Taylor TL; Shuster DJ; McIntyre KW; Shen DR; Yarde M; Cvijic ME; Marino AM; Balimane PV; Yang Z; Banas DM; Cornelius G; D'Arienzo CJ; Warrack BM; Lehman-McKeeman L; Salter-Cid LM; Xie J; Barrish JC; Carter PH; Dyckman AJ; Dhar TG
J Med Chem; 2016 Nov; 59(21):9837-9854. PubMed ID: 27726358
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-phosphate metabolism: A structural perspective.
Pulkoski-Gross MJ; Donaldson JC; Obeid LM
Crit Rev Biochem Mol Biol; 2015; 50(4):298-313. PubMed ID: 25923252
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Evaluation of Serinolamide Derivatives as Sphingosine-1-Phosphate-1 (S1P
Park SJ; Kim J; Kim J; Kim Y; Lee EH; Kim HJ; Kim S; Kim B; Kim R; Choi JW; Park JH; Park KD
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566164
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and Optimization of
Gusman DH; Shoemake C
Yale J Biol Med; 2017 Mar; 90(1):15-23. PubMed ID: 28356890
[TBL] [Abstract][Full Text] [Related]
14. The structure and function of the S1P1 receptor.
O'Sullivan C; Dev KK
Trends Pharmacol Sci; 2013 Jul; 34(7):401-12. PubMed ID: 23763867
[TBL] [Abstract][Full Text] [Related]
15. To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling.
Chew WS; Wang W; Herr DR
Pharmacol Res; 2016 Nov; 113(Pt A):521-532. PubMed ID: 27663260
[TBL] [Abstract][Full Text] [Related]
16. Benefit-Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis.
Comi G; Hartung HP; Bakshi R; Williams IM; Wiendl H
Drugs; 2017 Oct; 77(16):1755-1768. PubMed ID: 28905255
[TBL] [Abstract][Full Text] [Related]
17. Identification and synthesis of potent and selective pyridyl-isoxazole based agonists of sphingosine-1-phosphate 1 (S1P1).
Guo J; Watterson SH; Spergel SH; Kempson J; Langevine CM; Shen DR; Yarde M; Cvijic ME; Banas D; Liu R; Suchard SJ; Gillooly K; Taylor T; Rex-Rabe S; Shuster DJ; McIntyre KW; Cornelius G; D'Arienzo C; Marino A; Balimane P; Salter-Cid L; McKinnon M; Barrish JC; Carter PH; Pitts WJ; Xie J; Dyckman AJ
Bioorg Med Chem Lett; 2016 May; 26(10):2470-2474. PubMed ID: 27055941
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine 1-phosphate signaling at the blood-brain barrier.
Prager B; Spampinato SF; Ransohoff RM
Trends Mol Med; 2015 Jun; 21(6):354-63. PubMed ID: 25939882
[TBL] [Abstract][Full Text] [Related]
19. Second generation S1P pathway modulators: research strategies and clinical developments.
Bigaud M; Guerini D; Billich A; Bassilana F; Brinkmann V
Biochim Biophys Acta; 2014 May; 1841(5):745-58. PubMed ID: 24239768
[TBL] [Abstract][Full Text] [Related]
20. Selective Sphingosine 1-Phosphate Receptor 1 Agonist Is Protective Against Ischemia/Reperfusion in Mice.
Brait VH; Tarrasón G; Gavaldà A; Godessart N; Planas AM
Stroke; 2016 Dec; 47(12):3053-3056. PubMed ID: 27827329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
